Redefining Relief: Emerging Innovations in the Management of Pulmonary Arterial Hypertension

Redefining Relief: Emerging Innovations in the Management of Pulmonary Arterial Hypertension

Tuesday, August 20, 2024

Live Virtual Meeting

7:30 PM - 8:30 PM Eastern

For full accreditation information and to register, click here or go to:

https://clinicaloptions.com/events/pulmonary-arterial-hypertension/pulmonary-arterial-hypertension/11336-13397

Faculty

Vallerie V. McLaughlin, MD

Kim A. Eagle, MD Endowed Professor of Cardiovascular Medicine

Interim Chief Clinical Officer, Ambulatory Care Services

Director, Pulmonary Hypertension Program

Michigan Medicine

Ann Arbor, Michigan

Learning Objectives

Upon completion of this activity, learners should be able to:

·         Explain the pathophysiology, presentation, and risk of disease progression, emphasizing the role of early detection and diagnosis in enhancing patient outcomes

·         Construct a guideline-directed, personalized initial treatment plan for a patient with PAH

·         Outline evidence for emerging therapy approaches under investigation for management of PAH